| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |